Mark Willcox

27.9k total citations · 4 hit papers
622 papers, 21.0k citations indexed

About

Mark Willcox is a scholar working on Public Health, Environmental and Occupational Health, Ophthalmology and Molecular Biology. According to data from OpenAlex, Mark Willcox has authored 622 papers receiving a total of 21.0k indexed citations (citations by other indexed papers that have themselves been cited), including 357 papers in Public Health, Environmental and Occupational Health, 251 papers in Ophthalmology and 152 papers in Molecular Biology. Recurrent topics in Mark Willcox's work include Ocular Surface and Contact Lens (336 papers), Ocular Infections and Treatments (195 papers) and Corneal Surgery and Treatments (110 papers). Mark Willcox is often cited by papers focused on Ocular Surface and Contact Lens (336 papers), Ocular Infections and Treatments (195 papers) and Corneal Surgery and Treatments (110 papers). Mark Willcox collaborates with scholars based in Australia, United States and United Kingdom. Mark Willcox's co-authors include Fiona Stapleton, Naresh Kumar, Debarun Dutta, Hua Zhu, Judith Flanagan, Nerida Cole, Brien A. Holden, Ajay Kumar Vijay, Emma B.H. Hume and Muhammad Yasir and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Mark Willcox

603 papers receiving 20.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TFOS DEWS II Tear Film Report

2017 677 citations Mark Willcox, Eric Papas et al. The Ocular Surface profile →
TFOS DEWS II Report Executive Summary

2017 583 citations Jennifer P. Craig, José Álvaro Pereira Gomes et al. The Ocular Surface profile →
A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

2020 340 citations Renxun Chen, Mark Willcox et al. profile →
TFOS DEWS II Sex, Gender, and Hormones Report

2017 298 citations David A. Sullivan, Blanka Golebiowski et al. The Ocular Surface profile →

Peers

Countries citing papers authored by Mark Willcox

Since Specialization

Citations

This map shows the geographic impact of Mark Willcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Willcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Willcox more than expected).

Fields of papers citing papers by Mark Willcox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Willcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Willcox. The network helps show where Mark Willcox may publish in the future.

Co-authorship network of co-authors of Mark Willcox

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Willcox. A scholar is included among the top collaborators of Mark Willcox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Willcox. Mark Willcox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	β-Lactamase-activated antimicrobial dendron via the amine uncaging strategy 2025 ·Chemical Science ·Hao Luo, (unknown), (unknown), Jiangtao Xu, Rhiannon P. Kuchel, Shyam Kumar Mishra, Mark Willcox, Edgar H. H. Wong	0
2	Nasal colonization by potentially pathogenic bacteria, their antimicrobial susceptibility patterns, and risk factors for colonization among cancer patients at Dessie comprehensive specialized hospital, Northeast Ethiopia 2025 ·BMC Infectious Diseases ·N. Zaheer Ahmed, (unknown), Mark Willcox, (unknown), (unknown), Melaku Ashagrie Belete, Kirubel Eshetu, (unknown), (unknown), Daniel Gebretsadik	0
3	Zooming in on the intracellular microbiome composition of bacterivorous Acanthamoeba isolates 2024 ·ISME Communications ·Binod Rayamajhee, Mark Willcox, Savitri Sharma, (unknown), Constantinos Petsoglou, Paul R. Badenoch, Samendra P. Sherchan, Fiona L. Henriquez, Nicole Carnt	10
4	Characterization and Biofilm Inhibition of Multidrug‐Resistant Acinetobacter baumannii Isolates 2024 ·International Journal of Microbiology ·(unknown), (unknown), (unknown), Ananda Tiwari, Ranjit Sah, Anil Kumar Sah, (unknown), Mark Willcox, Shyam Kumar Mishra	6
5	The effect of immobilisation strategies on the ability of peptoids to reduce the adhesion of P. aeruginosa strains to contact lenses 2024 ·Experimental Eye Research ·(unknown), Sudip Chakraborty, Renxun Chen, Dennis Palms, (unknown), Zhong-Yan Li, Syamak Farajikhah, (unknown), Alex Hui, Edgar H. H. Wong, Naresh Kumar, Krasimir Vasilev, David W. MacKenzie, (unknown), (unknown), Håvard Jenssen, (unknown), Jennifer S Lin, Annelise E. Barron, Mark Willcox	3
6	TFOS Lifestyle: Impact of contact lenses on the ocular surface 2023 ·The Ocular Surface ·Lyndon Jones, Nathan Efron, (unknown), Melissa Barnett, Deborah S. Jacobs, Isabelle Jalbert, Heiko Pult, Michelle K. Rhee, Heather Sheardown, Joseph P. Shovlin, (unknown), (unknown), Jacqueline Tan, Silvia Tavazzi, Ömür Ö. Uçakhan, Mark Willcox, Laura E. Downie	35
7	TFOS Lifestyle Report Introduction: A Lifestyle Epidemic - Ocular Surface Disease 2023 ·The Ocular Surface ·Jennifer P. Craig, Mônica Alves, James S. Wolffsohn, Laura E. Downie, Nathan Efron, Anat Galor, José Álvaro Pereira Gomes, Lyndon Jones, Maria Markoulli, Fiona Stapleton, Christopher E. Starr, (unknown), Mark Willcox, David A. Sullivan	10
8	TFOS Lifestyle: Impact of nutrition on the ocular surface 2023 ·The Ocular Surface ·Maria Markoulli, Sumayya Ahmad, Jayashree Arcot, Reiko Arita, Jose Benitez-del-Castillo, Barbara Caffery, Laura E. Downie, Katie Edwards, Judith Flanagan, Marc Labétoulle, Stuti L. Misra, Małgorzata Mrugacz, Sumeer Singh, John D. Sheppard, Jelle Vehof, Piera Versura, Mark Willcox, (unknown), James S. Wolffsohn	21
9	A review of the antiviral activity of cationic antimicrobial peptides 2023 ·Peptides ·Umme Laila Urmi, Ajay Kumar Vijay, Rajesh Kuppusamy, Salequl Islam, Mark Willcox	34
10	Culture of primary human meibomian gland cells from surgically excised eyelid tissue 2023 ·Experimental Eye Research ·(unknown), Minh Anh Thu Phan, Michele C. Madigan, Fiona Stapleton, (unknown), Mark Willcox, Blanka Golebiowski	0
11	Effect of Deposition and Protease Digestion on the Ex Vivo Activity of Antimicrobial Peptide-Coated Contact Lenses 2023 ·Nanomaterials ·(unknown), Debarun Dutta, (unknown), Savitri Sharma, Naresh Kumar, Fiona Stapleton, Mark Willcox	7
12	Halogenated Dihydropyrrol-2-One Molecules Inhibit Pyocyanin Biosynthesis by Blocking the Pseudomonas Quinolone Signaling System 2022 ·Molecules ·Theerthankar Das, (unknown), Renxun Chen, (unknown), Frederik H. Kriel, Greg Whiteley, Trevor Glasbey, Jim Manos, Mark Willcox, Naresh Kumar	13
13	Biocompatibility and Comfort during Extended Wear of Mel4 Peptide-Coated Antimicrobial Contact Lenses 2022 ·Antibiotics ·(unknown), Debarun Dutta, (unknown), Pravin K. Vaddavalli, Savitri Sharma, Fiona Stapleton, Mark Willcox	2
14	Graphene- and Nanoparticle-Embedded Antimicrobial and Biocompatible Cotton/Silk Fabrics for Protective Clothing 2021 ·ACS Applied Bio Materials ·Shovon Bhattacharjee, Rakesh Joshi, Muhammad Yasir, Anurag Adhikari, Abrar Ahmad Chughtai, David Heslop, Rowena A. Bull, Mark Willcox, C. Raina MacIntyre	51
15	Treatment of Staphylococcus Aureus with Antibiotic and Quorum-Sensing Inhibitor Combinations Reduces Severity of Keratitis 2017 ·Mark Willcox, Emma B.H. Hume, (unknown), Naresh Kumar, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
16	A comparison of patient matched meibum and tear lipidomes 2013 ·QUT ePrints (Queensland University of Technology) ·Simon H. J. Brown, Carolina Kunnen, Eva Duchoslav, (unknown), Michael J. Kelso, Eric Papas, Percy Lazon de la Jara, Mark Willcox, Stephen J. Blanksby, Todd W. Mitchell	5
17	In Vivo Assessment of Antimicrobial Efficacy of Silver-Impregnated Contact Lens Storage Cases 2012 ·Investigative Ophthalmology & Visual Science ·(unknown), Hua Zhu, Mark Willcox, Jerome Ozkan, Thomas Naduvilath, Varghese Thomas, Fiona Stapleton	33
18	Bovine Lactoferrin Structures Promoting Corneal Epithelial Wound Healing In Vitro 2011 ·Investigative Ophthalmology & Visual Science ·(unknown), Qian Garrett, Mark Willcox	25
19	Ocular and neuronal cell apoptosis during HSV-1 infection: A review 2004 ·Current Eye Research ·(unknown), Mark Willcox, Sreedharan Athmanathan	14
20	Survival of Serratia marcescens in the Presence of Complement 2001 ·Microbial Ecology in Health and Disease ·Emma B.H. Hume, Mark Willcox	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact